Bayer

Stories

FDA approves first Factor XIa blood thinner for repeat strokes

Developer and marketer of Sunharbo (asundexian)

Roughly a quarter of the 795,000 Americans who have a stroke each year have had one before. On Monday the Food and Drug Administration approved Sunharbo, a daily pill from Bayer that cuts the risk of a second ischemic stroke by 26% when taken alongside existing antiplatelet therapy.

Updated 2 days ago

Sopris Capital buys Blackford Analysis, adding AI imaging orchestration to healthtech portfolio

Money Moves

Seller of Blackford Analysis

Azra AI completed its purchase of Blackford Analysis on October 20, 2026, adding the plumbing that runs other companies' imaging AI to a business that follows cancer patients after a scan. Blackford's platform connects more than 130 imaging applications from 45 vendors to a hospital's radiology workflow through one vendor-neutral connection.

Updated Oct 20